

Climara is a once-weekly Estradiol patch for menopause symptoms. Learn what it's used for, how to apply it, dosage, cost, and more.
Climara is a once-weekly prescription Estradiol transdermal patch used to treat menopause symptoms like hot flashes and vaginal dryness, and to prevent postmenopausal osteoporosis.
Climara is the brand name for an Estradiol transdermal system manufactured by Bayer HealthCare Pharmaceuticals. It was first approved by the FDA on December 22, 1994, making it one of the longest-established hormone replacement therapy patches on the market.
The active ingredient is Estradiol (sometimes written as 17β-estradiol), which is the most potent naturally occurring form of estrogen. Climara belongs to the Estrogens drug class. It is not a controlled substance but requires a prescription.
What makes Climara different from many other Estradiol patches is its once-weekly dosing schedule. While popular alternatives like Vivelle-Dot, Dotti, and Minivelle need to be changed twice a week, Climara delivers a steady dose of Estradiol for a full seven days from a single patch.
Generic versions of Climara are available from Mylan Technologies (approved 2000) and Zydus Pharmaceuticals (approved 2023). These generics are also once-weekly Estradiol patches and are FDA-rated as therapeutically equivalent to Climara.
Climara is FDA-approved for:
Climara is not approved for preventing heart disease, stroke, or dementia. In fact, its boxed warning states that it should not be used for these purposes, as it may increase those risks. For more on safety concerns, see our article on Climara side effects.
Climara is a thin, flat patch that sticks to your skin and releases Estradiol continuously for seven days. Here's how to use it:
Climara comes in six different strengths based on how much Estradiol the patch delivers per day:
Your doctor will typically start with the lowest effective dose and adjust based on your symptoms and response. Each box contains 4 patches (a one-month supply).
If your Climara patch falls off, try pressing it back into place. If it won't stick, apply a new patch to a different area and continue with your regular schedule. Don't apply two patches at the same time unless directed by your doctor.
Climara is not safe for everyone. You should not use Climara if you have:
Tell your doctor about your full medical history before starting Climara, especially if you have heart disease risk factors, a history of migraines, epilepsy, asthma, kidney disease, gallbladder disease, or endometriosis. See our article on Climara drug interactions for medications and supplements that may affect how Climara works.
Climara's cost depends on whether you use the brand-name version or a generic, and whether you have insurance:
For a full guide on reducing your costs, including manufacturer programs and patient assistance, see how to save money on Climara.
Climara and other Estradiol patches are currently affected by a nationwide supply shortage. Once-weekly patches like Climara have generally had more stable availability than twice-weekly patches, but supply still varies by pharmacy and location.
If you're having trouble finding Climara, use Medfinder to check pharmacy stock near you, or talk to your doctor about alternative options.
Climara has been a trusted hormone replacement therapy option for over 30 years. Its once-weekly application, multiple available strengths, and proven effectiveness make it a popular choice for managing menopause symptoms and preventing osteoporosis. Generic versions offer the same benefits at a lower cost.
If you're considering Climara, talk to your doctor about whether it's right for you — and if you need help finding it in stock, Medfinder is here to help.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.